Raytheon Wins $94M Army Deal For Excalibur 155mm Projectiles

 | Jun 18, 2018 06:29AM ET

Raytheon Company’s (NYSE:RTN) Missile Systems (MS) business unit recently won a $93.7 million modification contract for Excalibur 155mm projectiles. The contract was awarded by the U.S. Army Contracting Command, NJ.

Details of the Deal

Work related to the deal will be performed in Karlskoga, Sweden; South Plymouth and Glenrothes, the United Kingdom; and various locations across the United States.

The agreement is expected to get completed by Sep 30, 2020. Raytheon will utilize fiscal 2018 other procurement (Army) funds for completing the task.

Benefits of Excalibur 155mm Projectiles

Raytheon's Excalibur projectile is an extended range guided artillery shell that accurately extends the reach of .39-caliber artillery to 40 km and .52-caliber artillery to more than 50 km. Its overall precision, coupled with the ability to be integrated on multiple gun systems, enables both the U.S. and its coalition partners provide overmatch capabilities against land targets in a variety of combat environments, including stationary land targets.

Raytheon is currently developing a laser-guided version of the projectile, the Excalibur S, which incorporates a digital semi-active laser seeker, allowing it to strike moving targets without accurate location information. Further, it reduces the risk associated with GPS jamming.

Due to the variety of advantages it possesses, nations like Sweden, Canada, Australia and the Netherlands have already chosen the Excalibur precision-guided projectile to address vital security interests, while several other international militaries are finalizing procurement plans.

What’s Favoring Raytheon?

Increasing geo-political tensions across the globe have prompted nations to strengthen their defense systems manifold. With rapid technological development, missile defense has steadily emerged to play a pivotal role in a nation’s defense strategy.

To this end, Raytheon’s advanced MS segment has been clinching significant awards from the United States as well as international customers, courtesy of its high-end, combat-proven arsenals. The latest contract win is evidence to that.

Notably, the MS division recorded first-quarter 2018 net sales of $1,848 million, reflecting a 5% improvement from the year-ago quarter. We may expect the aforementioned contract to instill further growth in this segment, going ahead.

Moreover, Raytheon benefited from the fiscal 2018 appropriations bill that witnessed an increase of $150 million for its Excalibur program. In relation to this increased spending provisions, the company expects to acquire more bookings in 2018 and a favorable sales growth in 2019 and beyond.

Price Movement

Raytheon’s stock has improved about 22.7% in the last twelve months compared with the broader Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes